跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 23,499 条关于
“epithelial ovarian carcinomas”
全部
23,499
临床试验
21,408
药物
230
机构
10
资讯
1,851
去年
ANGLE's Parsortix System Enables Breakthrough Cancer Research Revealing CTC Clusters as Key Metastatic Drivers
去年
Study Finds HIPEC Does Not Improve Outcomes for Recurrent Epithelial Ovarian Cancer
去年
Novel Pan-Immune-Inflammation Nomogram Shows Promise in Predicting Epithelial Ovarian Cancer Outcomes
去年
Real-World Study Confirms Bevacizumab Benefits Limited to High-Risk Epithelial Ovarian Cancer Patients
去年
Niraparib Shows Promise in Extending Progression-Free Survival in Epithelial Ovarian Cancer
去年
Roche's VENTANA FOLR1 RxDx Assay Receives CE Mark for Ovarian Cancer Diagnosis
去年
Roche's VENTANA FOLR1 RxDx Assay Receives CE Mark for Ovarian Cancer Treatment Selection
去年
Cyclophosphamide and Trenimon Show Promise in Ovarian Carcinoma Treatment: Early In Vitro and Clinical Evidence
11年前
PARP Inhibitors Show Promise in Epithelial Ovarian and Breast Cancers with BRCA1/2 Mutations
去年
Neoadjuvant Chemotherapy Now Dominant Initial Treatment for Advanced Ovarian Cancer
第 1 页，共 186 页
上一页
下一页
